JPRN-UMIN000007575CompletedPhase 1
Positron emission tomography using a newly-developed PET probe: [18F] Fluoroacetate (FACE) - human volunteer study - - FACE volunteer study
Shiga Medical Center Research Institute0 sites4 target enrollmentStarted: April 1, 2012Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 4
Study Overview
Brief Summary
Annals of Nuclear Medicine Ann Nucl Med (2014) 28:371-380 Assessment of [18F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumor
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •a person with a disease (diseases)
Investigators
Similar Trials
Recruiting
Phase 1
[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast CancerAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaNCT06502691University of Washington22
Terminated
Phase 1
18F- Fluorothymidine to Evaluate Treatment Response in LymphomaLymphomaNCT00775268National Cancer Institute (NCI)31
Active, not recruiting
Phase 2
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast CancerBreast CarcinomaNCT05226663M.D. Anderson Cancer Center36
Withdrawn
Not Applicable
Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBMAstrocytoma, Grade IVGiant Cell GlioblastomaGlioblastoma MultiformeNCT00943462Centre hospitalier de l'Université de Montréal (CHUM)
Terminated
Phase 2
[18F]Fluciclatide PET Imaging of Pazopanib ResponseKidney NeoplasmNCT01961583Asan Medical Center12